Provention Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Provention Bio and buy or sell other stocks, ETFs, and their options commission-free!About PRVB
Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset.
CEOAshleigh W. Palmer, MBA
CEOAshleigh W. Palmer, MBA
Employees—
Employees—
HeadquartersRed Bank, New Jersey
HeadquartersRed Bank, New Jersey
Founded2016
Founded2016
Employees—
Employees—
PRVB Key Statistics
Market cap2.37B
Market cap2.37B
Price-Earnings ratio-16.32
Price-Earnings ratio-16.32
Dividend yield—
Dividend yield—
Average volume2.50M
Average volume2.50M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$25.00
52 Week high$25.00
52 Week low$3.19
52 Week low$3.19
People also own
Based on the portfolios of people who own PRVB. This list is generated using Robinhood data, and it’s not a recommendation.